Jacobs Levy Equity Management, Inc Clovis Oncology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $256,175 - $747,461	-67,951 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $90,897 - $497,812	-30,299 Reduced 30.84%	67,951 $708,000
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $334,050 - $1.3 Million	85,000 Added 641.51%	98,250 $386,000
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $169,732 - $340,127	13,250 New	13,250 $197,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.